ProShare Advisors LLC lessened its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS – Get Rating) by 10.9% during the first quarter, HoldingsChannel.com reports. The firm owned 3,441 shares of the company’s stock after selling 419 shares during the quarter. ProShare Advisors LLC’s holdings in Addus HomeCare were worth $322,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Northern Trust Corp increased its stake in Addus HomeCare by 10.4% during the 4th quarter. Northern Trust Corp now owns 285,427 shares of the company’s stock worth $26,690,000 after acquiring an additional 26,787 shares during the period. Virginia Retirement Systems ET AL acquired a new stake in shares of Addus HomeCare during the 1st quarter worth $252,000. Chatham Capital Group Inc. increased its position in shares of Addus HomeCare by 75.4% in the first quarter. Chatham Capital Group Inc. now owns 19,443 shares of the company’s stock worth $1,814,000 after purchasing an additional 8,357 shares during the period. Shell Asset Management Co. raised its stake in Addus HomeCare by 110.1% in the first quarter. Shell Asset Management Co. now owns 2,725 shares of the company’s stock valued at $254,000 after purchasing an additional 1,428 shares in the last quarter. Finally, MQS Management LLC bought a new stake in Addus HomeCare during the first quarter worth about $276,000. 95.03% of the stock is owned by institutional investors.
Insider Buying and Selling
In other news, COO W Bradley Bickham sold 3,797 shares of the firm’s stock in a transaction on Monday, August 15th. The shares were sold at an average price of $95.00, for a total transaction of $360,715.00. Following the completion of the transaction, the chief operating officer now owns 39,284 shares of the company’s stock, valued at $3,731,980. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, COO W Bradley Bickham sold 3,797 shares of the stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $95.00, for a total value of $360,715.00. Following the completion of the sale, the chief operating officer now owns 39,284 shares of the company’s stock, valued at $3,731,980. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP David W. Tucker sold 2,080 shares of Addus HomeCare stock in a transaction that occurred on Friday, July 15th. The stock was sold at an average price of $90.00, for a total value of $187,200.00. Following the completion of the transaction, the executive vice president now directly owns 8,468 shares in the company, valued at $762,120. The disclosure for this sale can be found here. Insiders have sold a total of 29,295 shares of company stock worth $2,752,735 in the last ninety days. Company insiders own 4.50% of the company’s stock.
Addus HomeCare Trading Up 0.7 %
Addus HomeCare (NASDAQ:ADUS – Get Rating) last announced its quarterly earnings results on Monday, August 1st. The company reported $0.91 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.01). Addus HomeCare had a net margin of 4.90% and a return on equity of 8.63%. The firm had revenue of $236.94 million for the quarter, compared to analyst estimates of $238.40 million. During the same period in the previous year, the business posted $0.78 earnings per share. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, sell-side analysts expect that Addus HomeCare Co. will post 3.16 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on ADUS shares. Stephens dropped their target price on shares of Addus HomeCare from $110.00 to $101.00 and set an “overweight” rating for the company in a research report on Tuesday, June 21st. Stifel Nicolaus initiated coverage on shares of Addus HomeCare in a research report on Tuesday, June 28th. They set a “buy” rating and a $101.00 price objective for the company. Royal Bank of Canada reduced their target price on Addus HomeCare from $111.00 to $110.00 and set an “outperform” rating on the stock in a report on Wednesday, August 3rd. StockNews.com cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 20th. Finally, Oppenheimer reduced their price objective on Addus HomeCare from $135.00 to $130.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 3rd. Six analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Addus HomeCare presently has an average rating of “Buy” and a consensus price target of $110.40.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.
- Get a free copy of the StockNews.com research report on Addus HomeCare (ADUS)
- MarketBeat Podcast: Stock Market, Bad News is Good News
- Forget Bitcoin, Block’s Ecosystems are the Real Growth Drivers
- What Does an Inverted Yield Curve Mean For You?
- SPY vs. QQQ: Which ETF Wins in 2022?
- Could Snap Stock Rebound As Management Restructures?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.